Aspeya

Investments

1

Lead Investments

0

Aspeya is a pharmaceutical manufacturing company headquartered in Stamford, Connecticut. It focuses on developing and commercializing consumer health and wellness products, including cannabinoids and nicotine replacement therapy products. Swissbiotech notes that Aspeya is owned by Philip Morris International, operates independently, and utilizes Fertin Pharma’s oral technology platform.